The 2027 Pershing Square Sohn Cancer Prize supports early-career scientists pursuing bold, high-risk research to advance cancer understanding, diagnosis, prevention, or treatment and address unmet needs.
The application portal for the 2027 Pershing Square Sohn Cancer Prize has closed; the Letter of Intent deadline was Monday, October 26, 2026, at 5:00 p.m. ET.
Pershing Square Sohn Cancer Prize supports early-career scientists pursuing bold, high-risk research to advance cancer understanding, diagnosis, prevention, or treatment and accelerate discoveries toward cures.
Pershing Square Sohn Cancer Prize supports early-career independent scientists pursuing bold cancer research to address unmet needs and advance cancer understanding, diagnosis, prevention, or treatment.
Pershing Square Lotus Award for Ovarian Cancer Research supports investigators pursuing bold cancer research with potential to advance ovarian cancer science, detection, and treatment toward a cure.
2027 MIND Prize supports early-to-mid-career investigators pursuing bold, hypothesis-driven neuroscience research to improve prediction, prevention, and treatment of neurodegenerative diseases.
PSC Partners Seeking a Cure's Research Grants Program supports investigators conducting basic and clinical research on PSC and closely associated diseases to advance treatments and a cure.